Category: Mass Tort Leads

Why We Adopted the Joint Advertising Compliance Program
February 7, 2026 by Mohr Marketing Why We Adopted the Joint Advertising Compliance Program (Even Though the Courts Said We Didn’t Have To) In the world of lead generation, there is “legal” and then there is “smart.” Earlier this year, the legal battle over the FCC’s “1-to-1 Consent Rule” resulted in the mandate being vacated. Technically, lead generators can go back… Continue reading Why We Adopted the Joint Advertising Compliance Program
FCC Lead Gen Rules FRCP Rule 16.1 FTC Compliance Mass Tort Best Practices Mass Tort Lead Generation MDL Compliance
What You Need to Know About the Hair Relaxer Lawsuit
February 7, 2026 by Mohr Marketing “Joint Advertising Compliance Program” to Combat “Vendor Fatigue” in Hair Relaxer Litigation If you are like most managing partners I talk to, you are suffering from “Vendor Fatigue.” You know the drill: You buy a batch of Hair Relaxer leads. Your intake team calls them. Half the numbers are disconnected. The other half say they… Continue reading What You Need to Know About the Hair Relaxer Lawsuit
Compliance Shield Hair Straightener Litigation
MDL 3140 Alert: The “Silent Risk” in Your 2026 Portfolio
February 7, 2026 by Mohr Marketing Pfizer. $3B+ Liquidity. 74 Million Users. Is your intake ready for the Depo-Provera docket? Usage Duration Verification The science relies on “cumulative dose.” We strictly screen for the “Duration of Use” criteria. The 1-Year Rule: Our funnels automatically reject cases where the user only received one or two injections. Re-Injection Confirmation: We verify that the… Continue reading MDL 3140 Alert: The “Silent Risk” in Your 2026 Portfolio
Compliance Shield Depo-Provera Liability Litigation
Get Signed, Vetted Meningioma Cases with the Compliance Shield
February 6, 2026 by Mohr Marketing 🛑 Stop Wasting Intake on “Headache” Calls (Depo-Provera Solution) The Depo-Provera MDL (3140) is moving fast. The science is strong (5.6x risk of Meningioma), and the defendant is solvent (Pfizer). But if you are buying raw leads, you are likely burning your intake team out on non-qualifying injuries. Stop buying “maybes.” Start buying Retainers. At… Continue reading Get Signed, Vetted Meningioma Cases with the Compliance Shield
Compliance Shield Depo-Provera Liability Litigation
The “Hard-Knock” Vetting Standard-Before You Ever See the File
February 6, 2026 by Mohr Marketing The “Hard-Knock” Vetting Standard We use a proprietary 5-step filtration process designed to disqualify 90% of general inquiries, leaving only the cases that survive a Motion to Dismiss. We don’t just ask “Did your child play?” We investigate the nexus of harm. What We Verify Before You Ever See the File: ✅ The Predator Contact:… Continue reading The “Hard-Knock” Vetting Standard-Before You Ever See the File
Compliance Shield Roblox Lawsuit
What You Need to Know About the Hair Relaxer Lawsuit
February 5, 2026 by Mohr Marketing Hidden Dangers: What You Need to Know About the Hair Relaxer Lawsuit For decades, chemical hair relaxers and straighteners have been a staple in the beauty routines of millions of women. However, a growing body of scientific evidence has uncovered a troubling link between these products and serious health issues, including uterine and ovarian cancer.… Continue reading What You Need to Know About the Hair Relaxer Lawsuit
Compliance Shield Hair Straightener Litigation
“Compliance Shield” Protocol for Depo-Provera MDL 3140
February 5, 2026 by Mohr Marketing “Compliance Shield” Protocol to Deliver Verified, Signed Plaintiffs for Depo-Provera MDL 3140 As the legal industry turns its attention to the rapidly maturing MDL 3140: In re: Depo-Provera Products Liability Litigation, Mohr Marketing announces the immediate availability of a specialized signed case acquisition program. This new offering allows law firms to build their pharmaceutical liability… Continue reading “Compliance Shield” Protocol for Depo-Provera MDL 3140
Compliance Shield Depo-Provera Liability Litigation
How to Build a High-Value Depo-Provera Docket (Intake Strategy)
February 4, 2026 by Mohr Marketing The Silent Signal: Why the Depo-Provera MDL is Your Firm’s Next Critical Docket With the docketing of MDL 3140 (In re: Depo-Provera Liability Litigation), firms have a massive opportunity to diversify their 2026 inventory—but only if they can solve the “Intake Integrity” challenge. Somewhere between the latest mass tort filings and the industry’s focus on… Continue reading How to Build a High-Value Depo-Provera Docket (Intake Strategy)
Compliance Shield Depo-Provera Liability Litigation
“Compliance Shield” Protocol for Roblox MDL 3166
February 4, 2026 by Mohr Marketing Compliance Shield Protocol to Deliver Verified, Signed Plaintiffs for Roblox MDL 3166 As the legal industry turns its attention to the emerging MDL 3166: In re: Roblox Child Sexual Exploitation and Assault Litigation, Mohr Marketing announces the immediate availability of a specialized signed case acquisition program. This new offering allows law firms to build their… Continue reading “Compliance Shield” Protocol for Roblox MDL 3166
Compliance Shield Roblox Lawsuit
Diversify Your 2026 Portfolio with the Roblox Docket
February 4, 2026 by Mohr Marketing MDL 3166 Alert: Diversify Your 2026 Portfolio with the Roblox Docket For law firms building their mass tort inventory for the coming year, a significant new opportunity is taking shape. The Judicial Panel on Multidistrict Litigation (JPML) has recently heard arguments to consolidate federal cases against Roblox Corporation into MDL 3166. If granted, this consolidation… Continue reading Diversify Your 2026 Portfolio with the Roblox Docket
Compliance Shield Roblox Lawsuit
Recent Posts
Categories
Archives

Copyright © 1994-2025 Mohr Marketing, LLC. All Rights Reserved.

Secret Link